Literature DB >> 28319337

Impact of mild to severe hemophilia on education and work by US men, women, and caregivers of children with hemophilia B: The Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study.

Susan Cutter1, Don Molter2, Spencer Dunn3, Susan Hunter4, Skye Peltier5, Kimberly Haugstad6, Neil Frick7, Natalia Holot8, David L Cooper8.   

Abstract

The psychosocial impact of hemophilia on work was recently investigated in the Hemophilia Experiences, Results and Opportunities (HERO) study. The findings revealed that hemophilia had an impact for adults with moderate/severe hemophilia and caregivers of children with hemophilia. HERO did not specifically evaluate impact on education in adults/children with mild/moderate hemophilia or the impact on employment of spouses/partners of caregivers of affected children. The Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study evaluated the impact of hemophilia on the lives of adult men/women with mild-severe hemophilia B and caregivers of boys/girls with hemophilia B and their spouses/partners. Many adults with hemophilia B (94%) reported that hemophilia had a negative effect on their ability to complete a formal education, often attributed to the inability to attend or concentrate in school as a result of hemophilia-related bleeding or pain. Most adults with hemophilia B (95%) and caregivers/partners (89%/84%) indicated that hemophilia had a negative impact on employment. Most adults with hemophilia were employed (81%), with construction/manufacturing (35%) as the most frequently reported industry; many worked in jobs requiring manual labor (39%). Of those unemployed, 62% never worked, and those who stopped working reported that they left the workforce due to financial issues (59%), including insurance coverage/co-pays, or hemophilia-related issues (55%). Nearly one-third of caregivers voluntarily left the workforce to care for children with hemophilia. These results suggest a need to focus more effort on career counseling for adults with hemophilia B and caregivers of affected children, especially around mild/moderate hemophilia, as this population may not be as well informed regarding potential impact in school and the workplace.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  education; employment; hemophilia B

Mesh:

Year:  2017        PMID: 28319337     DOI: 10.1111/ejh.12851

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  9 in total

1.  Hemophilia without prophylaxis: Assessment of joint range of motion and factor activity.

Authors:  Michael Wang; Michael Recht; Neeraj N Iyer; David L Cooper; J Michael Soucie
Journal:  Res Pract Thromb Haemost       Date:  2020-07-06

Review 2.  Phenotypical variability in congenital FVII deficiency follows the ISTH-SSC severity classification guidelines: a review with illustrative examples from the clinic.

Authors:  Shilpa Jain; Jennifer Donkin; Mary-Jane Frey; Skye Peltier; Sriya Gunawardena; David L Cooper
Journal:  J Blood Med       Date:  2018-11-19

3.  Education needs of nurses in thrombosis and hemostasis: An international, mixed-methods study.

Authors:  Patrice Lazure; James Munn; Sara Labbé; Suzanne Murray; Regina Butler; Kate Khair; Angela Lambing; Maura Malone; Thomas Reiser; Fiona Newall
Journal:  Res Pract Thromb Haemost       Date:  2018-11-01

4.  Health-related quality of life in paediatric haemophilia B patients treated with rIX-FP.

Authors:  Sylvia von Mackensen; Jinesh Shah; Wilfried Seifert; Gili Kenet
Journal:  Haemophilia       Date:  2018-11-14       Impact factor: 4.287

Review 5.  How to discuss gene therapy for haemophilia? A patient and physician perspective.

Authors:  Wolfgang Miesbach; Brian O'Mahony; Nigel S Key; Mike Makris
Journal:  Haemophilia       Date:  2019-05-21       Impact factor: 4.287

6.  Clinical, humanistic, and economic burden of severe hemophilia B in the United States: Results from the CHESS US and CHESS US+ population surveys.

Authors:  Tom Burke; Sohaib Asghar; Jamie O'Hara; Eileen K Sawyer; Nanxin Li
Journal:  Orphanet J Rare Dis       Date:  2021-03-20       Impact factor: 4.123

7.  Clinical, humanistic, and economic burden of severe haemophilia B in adults receiving factor IX prophylaxis: findings from the CHESS II real-world burden of illness study in Europe.

Authors:  Tom Burke; Sohaib Asghar; Jamie O'Hara; Margaret Chuang; Eileen K Sawyer; Nanxin Li
Journal:  Orphanet J Rare Dis       Date:  2021-12-20       Impact factor: 4.123

8.  A new measure to assess pain in people with haemophilia: The Multidimensional Haemophilia Pain Questionnaire (MHPQ).

Authors:  Ana Cristina Paredes; Patrício Costa; Armando Almeida; Patrícia R Pinto
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

Review 9.  Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy.

Authors:  Benjamin J Samelson-Jones; Valder R Arruda
Journal:  Mol Ther Methods Clin Dev       Date:  2018-12-31       Impact factor: 6.698

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.